FMC Corp

FMC Corp(FMC)股票分析

$5.050

+0.030 (+0.60%)收盘时

Loading chart…
最高
5.120
开盘
4.930
成交量加权均价
5.01
成交量
7.02M
市值
7.12B
最低
4.850
成交额
35.17M
企业价值/息税折旧摊销前利润(TTM)
6.84

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.

AI 分析 of FMC Corp (FMC)

卖出

FMC Corp is not a good buy right now due to severe financial challenges and a significant drop in revenue guidance. The current price is $5.05, and the company has cut its Q3 revenue outlook from $840-$900 million to a range of $65-$125 million, indicating a drastic decline in demand. Additionally, the RSI is at an extremely low 7.004, suggesting oversold conditions but also reflecting the ongoing bearish sentiment. The main risk is the projected adjusted EBITDA loss of $510 million to $565 million, which highlights the company's financial instability and could lead to further declines in stock value.

分析师评级(21)

上行空间 +277.82%
买入
13 买入
8 持有
0 卖出
当前: 5.05
最低
13.00
平均
19.08
最高
28.00

BMO Capital

2026-10-06

目标价

$11

Market Perform

UBS

2026-10-05

目标价

$10

中性

Seaport Research

2026-08-04

目标价

$21

买入

RBC Capital

2026-08-03

目标价

$11

Sector Perform

Morgan Stanley

2026-07-31

目标价

$12

Equal Weight

估值指标

FMC Corp(FMC)当前预期市盈率为 5.83,5 年平均预期市盈率为 14.22。

预期市盈率

低估
5 年均值 P/E
14.22
当前P/E
5.83
高估
20.01
低估
8.42

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
2.38
当前EV/EBITDA
6.84
高估
45.64
低估
-40.89

预期市销率

低估
5 年均值 P/S
1.72
当前P/S
0.22
高估
2.61
低估
0.83

Alphio AI 对 FMC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%FMC

$44.59

情景价格

基

基准

基准 · 50%FMC

$42.71

情景价格

悲

悲观

悲观 · 25%FMC

$40.23

情景价格

持有 FMC 的大户

H

HBK Investments L.P.

+ 持有FMC

+5.59%

3个月收益率

事件时间线

2026-10-15 (ET)

16:30:00

Dow Rises 556.21 Points, Nasdaq Ends Little Changed

12:30:00

Nasdaq Underperforms as Producer Price Index Rises 1.3% MoM

10:30:00

RBC Cuts FMC Q3 EBITDA Guidance to $538M

09:30:00

Tech Stocks Decline, Nasdaq and S&P 500 Suffer Major Drops

08:00:00

FMC Takes Actions to Address Slower Demand

资讯

FMC 常见问题 —— 由 Alphio AI 解答

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).

FMC Corp is not a good buy right now due to severe financial challenges and a significant drop in revenue guidance. The current price is $5.05, and the company has cut its Q3 revenue outlook from $840-$900 million to a range of $65-$125 million, indicating a drastic decline in demand. Additionally, the RSI is at an extremely low 7.004, suggesting oversold conditions but also reflecting the ongoing bearish sentiment. The main risk is the projected adjusted EBITDA loss of $510 million to $565 million, which highlights the company's financial instability and could lead to further declines in stock value.

21 analysts cover FMC: 13 rate it Buy, 8 Hold and 0 Sell. The average price target is 19.08.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易